Cost Analysis of Cervical Cancer in Antigua and Barbuda
Author Information
Author(s): Bovell Andre A. N., Ngcamphalala Cebisile, Abbott Dane, Ncayiyana Jabulani, Ginindza Themba G.
Primary Institution: University of KwaZulu-Natal
Hypothesis
This study aimed to estimate the economic burden of cervical cancer in Antigua and Barbuda from the healthcare provider’s perspective.
Conclusion
The total annual direct medical costs for managing cervical cancer in Antigua and Barbuda were estimated at approximately USD 238,439.76.
Supporting Evidence
- Cervical cancer is one of the most common cancers among women in Antigua and Barbuda.
- The total annual direct medical costs were estimated to be USD 238,439.76.
- Major cost drivers included treatment, post-treatment side-effects care, and the diagnostic process.
Takeaway
Cervical cancer is expensive to treat in Antigua and Barbuda, costing around a quarter of a million dollars each year for all patients combined.
Methodology
A prevalence-based cost-of-illness methodology was used to assess patient data from four study sites for the period 2017–2021.
Potential Biases
Retrospective data collection could have introduced biases due to inaccuracies in patient information recording.
Limitations
The study did not consider patient quality of care, quality of life, loss of productivity, and end-of-life care.
Participant Demographics
The study included 40 women diagnosed with cervical cancer, with an average age of 52 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website